Gone are the days when requesting facial filler at your dermatologist's office meant simply adding volume to, well, volume-less areas, like the lips. "Thanks to factors of availability, technological ...

Restylane has become one of the most recognizable names in injectable fillers, and its parent company, Galderma, has launched several hyaluronic acid (HA) subtypes over the last few years to serve a ...

This expands Galderma’s Restylane portfolio in Japan to four products, enabling treatment of a wider spectrum of patient and practitioner needs 3,4 These two new launches underscore Galderma’s ...

Restylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement ...

Results showed that 74% of Restylane Defyne-treated patients achieved significantly improved chin projection for up to 1 year. The Food and Drug Administration (FDA) has approved Restylane ® Defyne ...

Galderma, the brand behind fillers like Restylane, Dysport and Sculptra Aesthetic, announced today the FDA approval of two new fillers to the Restylane category: Restylane Refyne and Restylane Defyne.

There's a new filler in town (actually, two new fillers) and they're billed as the next big thing in the fight against laugh lines. Galderma, the pharmaceutical company behind injectables like ...

Galderma, the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT-based hyaluronic acid injectables ever authorized in Japan. The ...

(MENAFN- PR Newswire) FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and ...

Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Restylane Defyne for mild to moderate chin retrusion augmentation in adults older than 21 ...